NSE: COLPAL | BSE: 500830

Expensive Performer

Download real time

2183.40 2.70 (0.12%)

Near 52W Low of ₹2151.00

303.4K NSE+BSE Volume

NSE 19 Nov, 2025 3:31 PM (IST)

59,385.3

Market Cap

High in industry

0.6

Beta 1Year

Very Low volatility

Colgate-Palmolive (India) Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for COLPAL, BSE:500830 Colgate-Palmolive (India) Ltd.

Colgate-Palmolive (India) Ltd.

22 Jul 2025

2183.40

0.12%

Poor start to FY26

Buy: Colgate-Palmolive (India) ...

Target

Sharekhan

Colgate’s Q1FY26 performance was weak with numbers missing estimates on all fronts. Standalone revenues declined by 4.2% y-o-y to Rs. 1,434 crore, missing our and the average street’s expectation of Rs. 1,525 crore and Rs. 1,498 crore, respectively.

Colgate-Palmolive (India) Ltd. is trading below all available SMAs

Colgate-Palmolive (India) Ltd.

27 May 2025

2183.40

0.12%

Soft Q4; recovery to be gradual

Buy: Colgate-Palmolive (India) ...

Recommendation Target

Sharekhan

Colgate’s Q4FY25 performance was muted owing to soft demand in urban markets and heightened competitive intensity. Standalone revenues declined by 1.8% y-o-y to Rs. 1,463 crore, missing our expectation of Rs. 1,520 crore, with toothpaste volumes flat y-o-y.

Geojit BNP Paribas upgraded Colgate-Palmolive (India) Ltd. to Buy with a price target of 2550.0 on 06 Nov, 2025.

Colgate-Palmolive (India) Ltd.

22 May 2025

2183.40

0.12%

Colgate Palmolive (CLGT IN) Q4FY25 Result Update Urban...

Hold: Colgate-Palmolive (India) ...

Target

Prabhudas Lilladhar

Cautious outlook for 1H26 due to muted urban demand, expect recovery led by innovations & rural momentum post 2Q. increased promotional spending led by heightened competitive intensity. Near term outlook is cautious given that 1) urban demand continues to remain muted at mass end 2) heightened competitive landscape 3) rising promotional...

Colgate-Palmolive (I.. has an average target of 2552.50 from 8 brokers.

Colgate-Palmolive (India) Ltd.

22 May 2025

2183.40

0.12%

The worst (for the stock) is yet to come

Sell: Colgate-Palmolive (India) ...

Recommendation Target

ICICI Securities Limited

We've been long critical of Colgate India's (consistent) strategy of not investing (enough) for toothpaste category growth (our opinion), not aggressive (enough) in diversifying outside of oralcare (parent has a good HPC portfolio though), over-earning, in our opinion (operating margins at ~37% after adding back royalty).

Colgate-Palmolive (India) Ltd. is trading below all available SMAs

Colgate-Palmolive (India) Ltd.

11 Mar 2025

2183.40

0.12%